PMID- 22999069
OWN - NLM
STAT- MEDLINE
DCOM- 20130510
LR  - 20220309
IS  - 1746-1596 (Electronic)
IS  - 1746-1596 (Linking)
VI  - 7
DP  - 2012 Sep 21
TI  - Primary mesenchymal chondrosarcoma of the kidney with synchronous implant and 
      infiltrating urothelial carcinoma of the ureter.
PG  - 125
LID - 10.1186/1746-1596-7-125 [doi]
AB  - Primary mesenchymal chondrosarcoma of the kidney is rare, and it shows distinct 
      undifferentiated tumor cells and well differentiated cartilagenous components. 
      Also assident infiltrating urothelial carcinoma of the ureter is an extremely 
      rare cancer. We report a case of primary mesenchymal chondrosarcoma occurring in 
      the left kidney with an ipsilateral and distinct distal ureteric implant, and a 
      coexisting infiltrating urothelial carcinoma of the ureter in a 64-year-old man. 
      Histopathological examination and immunohistochemical studuies showed the classic 
      features of mesenchymal chondrosarcoma in kidney, as well as a few infiltrating 
      urothelial in ureter. Multitarget fluorescence in situ hybridization (FISH) 
      suggested that the development of the urothelial carcinoma in the ureter may be 
      triggered or induced by the chondrosarcoma component. The patient died 2 month 
      after left nephro-ureterectomy. This is the first reported case of a primary 
      mesenchymal chondrosarcoma of the kidney with coexisting infiltrating urothelial 
      carcinoma of the ureter. VIRTUAL SLIDES: The virtual slide(s) for this article 
      can be found here: 
      http://www.diagnosticpathology.diagnomx.eu/vs/1522835667751019.
FAU - Xu, Hua
AU  - Xu H
AD  - Departments of Pathology, Shenzhen Affiliated Hospital, Guangzhou University of 
      Traditional Chinese Medicine, Shenzhen, China.
FAU - Shao, MuMin
AU  - Shao M
FAU - Sun, HuiLi
AU  - Sun H
FAU - Li, ShunMin
AU  - Li S
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20120921
PL  - England
TA  - Diagn Pathol
JT  - Diagnostic pathology
JID - 101251558
RN  - 0 (Biomarkers, Tumor)
SB  - IM
MH  - Biomarkers, Tumor/analysis/genetics
MH  - Carcinoma/chemistry/genetics/*pathology/surgery
MH  - Chondrosarcoma, Mesenchymal/chemistry/genetics/*pathology/surgery
MH  - Fatal Outcome
MH  - Humans
MH  - Immunohistochemistry
MH  - In Situ Hybridization, Fluorescence
MH  - Kidney Neoplasms/chemistry/genetics/*pathology/surgery
MH  - Male
MH  - Middle Aged
MH  - Neoplasms, Multiple Primary/chemistry/genetics/*pathology/surgery
MH  - Nephrectomy
MH  - Treatment Outcome
MH  - Ureter/chemistry/*pathology/surgery
MH  - Ureteral Neoplasms/chemistry/genetics/*pathology/surgery
PMC - PMC3533729
EDAT- 2012/09/25 06:00
MHDA- 2013/05/11 06:00
PMCR- 2012/09/21
CRDT- 2012/09/25 06:00
PHST- 2012/06/19 00:00 [received]
PHST- 2012/09/17 00:00 [accepted]
PHST- 2012/09/25 06:00 [entrez]
PHST- 2012/09/25 06:00 [pubmed]
PHST- 2013/05/11 06:00 [medline]
PHST- 2012/09/21 00:00 [pmc-release]
AID - 1746-1596-7-125 [pii]
AID - 10.1186/1746-1596-7-125 [doi]
PST - epublish
SO  - Diagn Pathol. 2012 Sep 21;7:125. doi: 10.1186/1746-1596-7-125.